RRC
63
3
ETR
68
3
CSCO
63
2
DLTR
34
-4
AVGO
20
-5
PVH
52
-3
WMT
74
2
EIX
77
2
HAS
30
2
ROK
55
8
PRU
57
-3
FOXA
55
9
CINF
47
2
ALLE
37
5
TXT
48
2
WDC
41
-2
BBY
40
3
BAC
50
-3
MTB
63
-2
MRK
22
3
RRC
63
3
ETR
68
3
CSCO
63
2
DLTR
34
-4
AVGO
20
-5
PVH
52
-3
WMT
74
2
EIX
77
2
HAS
30
2
ROK
55
8
PRU
57
-3
FOXA
55
9
CINF
47
2
ALLE
37
5
TXT
48
2
WDC
41
-2
BBY
40
3
BAC
50
-3
MTB
63
-2
MRK
22
3
Financhill
Back

Novo Nordisk AS Stock Price Chart

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
34

NONOF
Novo Nordisk AS

Last Price:
105.49
Seasonality Move:
10.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

Novo Nordisk AS Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 104.24 Buy
20-day SMA: 108.18 Sell
50-day SMA: 116.71 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.48 Buy
20-day EMA: 107.97 Sell
50-day EMA: 115.05 Sell
200-day EMA: 120.69 Sell

Novo Nordisk AS Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.96 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: 32377 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.78 - 115) Sell
Bollinger Bands (100): (113.85 - 136.93) Sell

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Novo Nordisk AS Stock

Is Novo Nordisk AS Stock a Buy?

  • Novo Nordisk AS share price is 105.49 while NONOF 8-day simple moving average is 104.24, which is a Buy signal.
  • The stock price of NONOF is 105.49 while Novo Nordisk AS 20-day SMA is 108.18, which makes it a Sell.
  • Novo Nordisk AS 50-day simple moving average is 116.71 while NONOF share price is 105.49, making it a Sell technically.
  • NONOF stock price is 105.49 and Novo Nordisk AS 200-day simple moving average is 127.84, creating a Sell signal.

NONOF Technical Analysis vs Fundamental Analysis

Sell
34
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy or a Sell?

  • Novo Nordisk AS stock is rated a Sell
    The current Novo Nordisk AS [NONOF] share price is $105.49. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.

Novo Nordisk AS Stock Info

Market Cap:
468.73B
Price in USD:
105.49
Share Volume:
54.89K

Novo Nordisk AS 52-Week Range

52-Week High:
149.55
52-Week Low:
94.36
Sell
34
Novo Nordisk AS (NONOF) is a Sell

Novo Nordisk AS Share Price Forecast

Is Novo Nordisk AS Stock a Buy?

  • Novo Nordisk AS share price is 105.49 while NONOF 8-day exponential moving average is 104.48, which is a Buy signal.
  • The stock price of NONOF is 105.49 while Novo Nordisk AS 20-day EMA is 107.97, which makes it a Sell.
  • Novo Nordisk AS 50-day exponential moving average is 115.05 while NONOF share price is 105.49, making it a Sell technically.
  • NONOF stock price is 105.49 and Novo Nordisk AS 200-day simple moving average is 120.69, creating a Sell signal.

Fundamental Analysis of Novo Nordisk AS

Is Novo Nordisk AS a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Technical Analysis of Novo Nordisk AS

Should I short Novo Nordisk AS stock?

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.